Vascular Patches Market to Surpass Us$ 7,665.5 Million by 2027, a Cagr of 7.0% During the Forecast Period (2020-2027)

Vascular Patches Market Expected to Exceed $7.66 Billion by 2027

Vascular patches are used for reconstruction of a damaged artery in the cardiovascular surgeries. It is usually placed at the site infection, which helps in reconstruction and maintenance of carotid arteries in postoperative wound infection. The vascular patches allows positive and safe angioplasty of an artery to be performed in an infected operation site. Rising aging population is expected to drive the global vascular patches market growth. For instance, according to an article published by the World Health Organization (WHO) in February 2018, the proportion of the worldwide geriatric population will nearly double from 12% to 22% between 2015 and 2050.

Moreover, the rising prevalence of cardiovascular diseases is expected to drive the market growth. For instance, according to an article titled ‘Heart Disease and Stroke Statistics-2019’, published by the American College of Cardiology Foundation in 2019, around 795,000 U.S. populace have new or recurrent stroke annually, in which 90.0% of stroke risk is due to modifiable risk factors and 74.0% is due to behavioral risk factors.

Request Sample Copy + related graphs of the report@ https://www.coherentmarketinsights.com/insight/request-sample/4371

Key players operating in the global vascular patches market are developing novel products, which is expected to boost the global vascular patches market growth. For instance, in May 2015, Admedus Limited, a medical technologies company, launched CardioCel, a new tissue patch for vascular repairs such as carotid endarterectomies. The company expand the use of CardioCel across a range of surgical applications.

Since the COVID-19 virus outbreak in December 2019, the disease has spread to over 100 countries across the globe and the World Health Organization has declared it a public health emergency. According to the World Health Organization’s report, the manifestation of coronavirus disease (COVID-19) has resulted in over 80.77 million infected individuals worldwide, as of December 30, 2020.

COVID-19 can affect the economy in three main ways; by directly affecting production and demand, by creating disruptions in distribution channel, and by its financial impact on firms and financial markets. Due to nationwide lockdowns, several countries such as Saudi Arabia, UAE, Egypt, and others are facing problems with regards to transportation of raw materials from one place to another.

Detailed Segmentation:

By Type:

• • Biologic Vascular Patches
  • Synthetic Vascular Patches

By Application:

• • Carotid Endarterectomy
  • Aortic Aneurysms
  • Profundaplasty
  • Others

By End User:

• • Hospitals and Clinics
  • Ambulatory Surgical Centers
  • Others

Request Here For PDF Brochure:
https://www.coherentmarketinsights.com/insight/request-pdf/4371

Major players operating in the global vascular patches market include B. Braun Melsungen AG, C. R. Bard, Inc., LeMaitre Vascular, Inc., Getinge AB (Maquet), W. L. Gore & Associates, Inc., Edwards Lifesciences Corporation, Baxter International Inc., CryoLife, Inc., Medtronic, and Admedus, among others.

Contact:

Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837

The post Vascular Patches Market to Surpass US$ 7,665.5 Million by 2027, a CAGR of 7.0% during the forecast period (2020-2027) appeared first on Gatorledger.